ES2368899T3 - Composiciones para el tratamiento y el diagnóstico de cáncer de mama y métodos para el uso de las mismas. - Google Patents

Composiciones para el tratamiento y el diagnóstico de cáncer de mama y métodos para el uso de las mismas. Download PDF

Info

Publication number
ES2368899T3
ES2368899T3 ES00919352T ES00919352T ES2368899T3 ES 2368899 T3 ES2368899 T3 ES 2368899T3 ES 00919352 T ES00919352 T ES 00919352T ES 00919352 T ES00919352 T ES 00919352T ES 2368899 T3 ES2368899 T3 ES 2368899T3
Authority
ES
Spain
Prior art keywords
polypeptide
polynucleotide
patient
cells
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00919352T
Other languages
English (en)
Spanish (es)
Inventor
Jiang Yuqiu
Davin C. Dillon
Jennifer Lynn Mitcham
Jiangchun Xu
Susan L. Harlocker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ES2368899T3 publication Critical patent/ES2368899T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES00919352T 1999-04-02 2000-02-15 Composiciones para el tratamiento y el diagnóstico de cáncer de mama y métodos para el uso de las mismas. Expired - Lifetime ES2368899T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US389681 1982-06-18
US285480 1988-12-16
US09/285,480 US6590076B1 (en) 1999-04-02 1999-04-02 Compositions for the treatment and diagnosis of breast cancer and methods for their use
US433826 1999-11-03
US339338 2006-01-25

Publications (1)

Publication Number Publication Date
ES2368899T3 true ES2368899T3 (es) 2011-11-23

Family

ID=27804894

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00919352T Expired - Lifetime ES2368899T3 (es) 1999-04-02 2000-02-15 Composiciones para el tratamiento y el diagnóstico de cáncer de mama y métodos para el uso de las mismas.

Country Status (5)

Country Link
US (2) US6590076B1 (cg-RX-API-DMAC7.html)
JP (2) JP4806124B2 (cg-RX-API-DMAC7.html)
AT (1) ATE514780T1 (cg-RX-API-DMAC7.html)
ES (1) ES2368899T3 (cg-RX-API-DMAC7.html)
ZA (1) ZA200108065B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7414112B2 (en) * 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6774226B1 (en) * 1999-11-30 2004-08-10 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
WO2002022777A2 (fr) * 2000-09-15 2002-03-21 Institut National De La Sante Et De La Recherche Medicale (Inserm) Genes cellulaires impliques dans l'oncogenese, les produits de ces genes et leurs applications diagnostiques et therapeutiques
EP1695078A4 (en) * 2003-11-13 2007-07-11 Burnham Inst METADHERINE POLYPEPTIDES, CODING NUCLEIC ACIDS AND METHOD OF USE
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006280A1 (en) 1988-01-04 1989-07-13 E.I. Du Pont De Nemours And Company Multiple stage affinity process for isolation of specific cells from a cell mixture
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
DK0553288T3 (da) 1990-10-18 1997-12-29 Cellpro Inc Apparat og fremgangsmåde til udskillelse af partikler ved brug af en eftergivende beholder
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
DE69637552D1 (de) 1995-03-17 2008-07-10 Wayne John Cancer Inst Nachweis von Brustmetastasen unter Verwendung eines Mehrfachmarker-Tests
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
US5891857A (en) 1996-02-20 1999-04-06 Vanderbilt University Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins
CA2269634C (en) * 1996-10-31 2010-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1998021331A1 (en) 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
WO1998033915A1 (en) 1997-02-03 1998-08-06 Human Genome Sciences, Inc. Breast cancer specific gene 1
EP1039801A4 (en) 1997-06-06 2003-03-26 Human Genome Sciences Inc 207 HUMAN SECRETED PROTEINS
US20020018990A1 (en) * 1997-06-20 2002-02-14 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
EP1005544A4 (en) 1997-08-19 2004-07-14 Human Genome Sciences Inc 70 HUMAN, SECRETED PROTEINS
WO2000008210A1 (en) 1998-08-04 2000-02-17 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
US6579973B1 (en) 1998-12-28 2003-06-17 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
DE60044119D1 (de) 1999-01-21 2010-05-20 Abbott Lab Reagentien und verfahren zur erkennung von erkrankungen der brust
WO2000073801A2 (en) 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
WO2001037779A2 (en) 1999-11-23 2001-05-31 Diadexus, Inc. A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
EP1261704B1 (en) 1999-11-30 2009-07-01 Ludwig Institute For Cancer Research Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof

Also Published As

Publication number Publication date
ATE514780T1 (de) 2011-07-15
US20030229020A1 (en) 2003-12-11
JP2010239970A (ja) 2010-10-28
JP4806124B2 (ja) 2011-11-02
US6590076B1 (en) 2003-07-08
ZA200108065B (en) 2003-03-06
JP2002540789A (ja) 2002-12-03

Similar Documents

Publication Publication Date Title
ES2308976T3 (es) Compuestos y metodos para la terapia y el diagnostico del cancer de pulmon.
EP1183348B1 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
EP1141290B1 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
ES2277432T3 (es) Compuestos y metodos para terapia y diagnosis de cancer de pulmon.
EP1870466A2 (en) Compositions and methods for therapy and diagnosis of prostate cancer
WO2002013847A2 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
CA2383615A1 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
JP2010239970A (ja) 乳癌の処置および診断のための組成物ならびにそれらの使用方法
US20010055596A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
US20020150588A1 (en) SPAS-1 cancer antigen
WO2000052165A2 (en) Compositions and methods for breast cancer therapy and diagnosis
JP2002540789A5 (cg-RX-API-DMAC7.html)
WO2001051513A2 (en) Ovarian tumor-associated sequences
ES2350041T3 (es) Composiciones y métodos para la terapia y diagnóstico del cáncer de ovarios.
US20020058292A1 (en) Ovarian tumor antigen and methods of use therefor
US6933363B1 (en) Compositions and methods for therapy and diagnosis of lung cancer
US20020155468A1 (en) Ovarian tumor antigen and methods of use therefor
JP4942906B2 (ja) 卵巣癌の治療および診断のための組成物および方法
ES2315296T3 (es) Composiciones para la terapia uy el diagnostico del cancer ovarico.
AU2007216683B2 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
US20030157119A1 (en) Methods for diagnosis and therapy of hematological and virus-associated malignancies
WO2001027276A2 (en) Dna sequences from breast tumor and uses thereof
KR20010101242A (ko) 난소암의 치료 및 진단용 조성물 및 방법
CA2613125A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer